Spiro-benzo[c]chromene derivatives useful as modulators of the estrogen receptors
AssigneeJanssen Pharmaceutica NV
InventorsXuqing Zhang, Zhihua Sui
Life of this patent
Estimating the term…
Abstract
The present invention is directed to novel spiro-benzo[C]chromene derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders mediated by one or more estrogen receptors. The compounds of the invention are useful in the treatment of disorders associated with the depletion of estrogen such as hot flashes, vaginal dryness, osteopenia and osteoporosis; hormone sensitive cancers and hyperplasia of the breast, endometrium, cervix and prostate; endometriosis, uterine fibroids, osteoarthritis and as contraceptive agents, alone or in combination with a progestogen or progestogen antagonist.
Claims7
A compound of formula (I)
- wherein
- represents a single or double bond,
- X, Y are selected from the group consisting of O, S, SO and SO2;
- Z is selected from the group consisting of O and S;
- R1 is selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl and heteroaryl-alkyl;
- wherein the cycloalkyl, aryl, aralkyl, heteroaryl or heteroaryl-alkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, —SH, —S(alkyl), SO2, NO2, CN, CO2H, RC, —ORC, —SO2—NRDRE, —NRDRE, NRD—SO2—RF, -(alkyl)0-4-C(O)NRDRE, (alkyl)0-4-NRD—C(O)—RF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-NRDRE, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—ORF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—NRDRE or -(alkyl)0-4-C(O)-(alkyl)0-4-C(O)—ORF;
- wherein RC is selected from the group consisting of alkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, heterocycloalkyl and heterocycloalkyl-alkyl;
- wherein the cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, heterocycloalkyl or heterocycloalkyl-alkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, —SH, —S(alkyl), SO2, NO2, CN, CO2H, RC, —SO2—NRDRE, NRDRE, NRD—SO2—RF, -(alkyl)0-4-C(O)—NRDRE, (alkyl)0-4—NRD—C(O)—RF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-NRDRE, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—ORF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—NRDRE or -(alkyl)0-4-C(O)-(alkyl)0-4-C(O)—ORF;
- wherein Q is selected from the group consisting of O, S, NH, N(alkyl) and —CH═CH—;
- wherein RD and RE are each independently selected from the group consisting of hydrogen and alkyl;
- alternatively RD and RE are taken together with the nitrogen atom to which they are bound to form a 4 to 8 membered ring selected from the group consisting of heteroaryl or heterocycloalkyl;
- wherein the heteroaryl or heterocycloalkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, carboxy, amino, alkylamino, dialkylamino, nitro or cyano;
- wherein RF is selected from the group consisting of hydrogen, alkyl, cycloalkyl, cycloalkyl-alkyl, aryl, aralkyl, heteroaryl, heteroaryl-alkyl, heterocycloalkyl and heterocycloalkyl-alkyl;
- wherein the cycloalkyl, aryl, heteroaryl, heteroaryl-alkyl, heterocycloalkyl or heterocycloalkyl-alkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, carboxy, amino, alkylamino, dialkylamino, nitro or cyano;
- R2 is selected from the group consisting of hydroxy, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl and heteroaryl-alkyl;
- wherein the cycloalkyl, aryl, aralkyl, heteroaryl or heteroaryl-alkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, —SH, —S(alkyl), SO2, NO2, CN, CO2H, RC, —ORC, —SO2—NRDRE, —NRDRE, NRD—SO2—RF, -(alkyl)0-4-C(O)NRDRE, (alkyl)0-4-NRD—C(O)—RF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-NRDRE, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—ORF, -(alkyl)0-4-(Q)0-1-(alkyl)0-4-C(O)—NRDRE or -(alkyl)0-4-C(O)-(alkyl)0-4-C(O)—ORF;
- alternatively, R1 and R2 are taken together with the carbon atom to which they are bound to form C(O);
- m is an integer selected from 0 to 4;
- R3 is independently selected from the group consisting of halogen, hydroxy, RC, amino, alkylamino, dialkylamino, nitro, cyano, SO2, —C(O)RG, —C(O)ORG, —OC(O)RG, —OC(O)ORG, —OC(O)N(RG)2, —N(RG)C(O)RG, —OSi(RG)3—ORG, —SO2N(RG)2, —O-(alkyl)1-4-C(O)RG and —O-(alkyl)1-4-C(O)ORG;
- wherein each RG is independently selected from hydrogen, alkyl, aryl, aralkyl and 1,7,7-trimethyl-2-oxabicyclo[2.2.1]heptan-3-one;
- wherein the alkyl, aryl or aralkyl group is optionally substituted with one or more substituents independently selected from alkyl, halogenated alkyl, alkoxy, halogen, hydroxy, nitro, cyano, —OC(O)-alkyl or —C(O)O-alkyl;
- alternatively two RG groups are taken together with the nitrogen atom to which they are bound to form a heterocycloalkyl group;
- wherein the heterocycloalkyl group is optionally substituted with one or more substituents independently selected from halogen, hydroxy, alkyl, alkoxy, carboxy, amino, alkylamino, dialkylamino, nitro or cyano;
- I is an integer selected from 0, 1.
Dependencies are inferred from the claim text.